Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Estimation of US SARS-CoV-2 Infections, Symptomatic Infections, Hospitalizations, and Deaths Using Seroprevalence Surveys
Frederick J. Angulo, Lyn Finelli, David L. Swerdlow
JAMA Network Open (2021) Vol. 4, Iss. 1, pp. e2033706-e2033706
Open Access | Times Cited: 138

Showing 26-50 of 138 citing articles:

Quarantine and testing strategies to ameliorate transmission due to travel during the COVID-19 pandemic: a modelling study
Chad R. Wells, Abhishek Pandey, Meagan C. Fitzpatrick, et al.
The Lancet Regional Health - Europe (2022) Vol. 14, pp. 100304-100304
Open Access | Times Cited: 26
Public health impact of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) in the first year of rollout in the United States
Manuela Di Fusco, Kinga Marczell, Kristen A. Deger, et al.
Journal of Medical Economics (2022) Vol. 25, Iss. 1, pp. 605-617
Open Access | Times Cited: 26
Rheumatologic Manifestations of Post SARS-CoV-2 Infection: A Case Series
Samy Metyas, Christina Chen, Tun Aung, et al.
Current Rheumatology Reviews (2022) Vol. 18, Iss. 4, pp. 346-351
Closed Access | Times Cited: 22
Population-Weighted Seroprevalence From Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, Vaccination, and Hybrid Immunity Among US Blood Donations From January to December 2021
Michael P. Busch, Susan L. Stramer, Mars Stone, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. Supplement_2, pp. S254-S263
Open Access | Times Cited: 21
Green spaces, especially nearby forest, may reduce the SARS-CoV-2 infection rate: A nationwide study in the United States
Bin Jiang, Yuwen Yang, Long Chen, et al.
Landscape and Urban Planning (2022) Vol. 228, pp. 104583-104583
Open Access | Times Cited: 20
Incidence of symptomatic Lyme borreliosis in nine European countries
Frederick J. Angulo, Emily Colby, Anne‐Mette Lebech, et al.
International Journal of Infectious Diseases (2024) Vol. 149, pp. 107242-107242
Open Access | Times Cited: 3
Estimates of Cases and Hospitalizations Averted by COVID-19 Case Investigation and Contact Tracing in 14 Health Jurisdictions in the United States
Seonghye Jeon, Gabriel Rainisch, R. Ryan Lash, et al.
Journal of Public Health Management and Practice (2021) Vol. 28, Iss. 1, pp. 16-24
Open Access | Times Cited: 23
Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 After the Second Wave in South Africa in Human Immunodeficiency Virus–Infected and Uninfected Persons: A Cross-Sectional Household Survey
Nicole Wolter, Stefano Tempia, Anne von Gottberg, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. 1, pp. e57-e68
Open Access | Times Cited: 16
The Importance of Incorporating At-Home Testing Into SARS-CoV-2 Point Prevalence Estimates: Findings From a US National Cohort, February 2022
Saba A Qasmieh, McKaylee Robertson, Madhura S. Rane, et al.
JMIR Public Health and Surveillance (2022) Vol. 8, Iss. 12, pp. e38196-e38196
Open Access | Times Cited: 16
Relative role of border restrictions, case finding and contact tracing in controlling SARS-CoV-2 in the presence of undetected transmission: a mathematical modelling study
Rachael Pung, Hannah Clapham, Timothy Russell, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 9
History of primary-series and booster vaccination and protection against Omicron reinfection
Hiam Chemaitelly, Houssein H. Ayoub, Patrick Tang, et al.
Science Advances (2023) Vol. 9, Iss. 40
Open Access | Times Cited: 9
Incorporating false negative tests in epidemiological models for SARS-CoV-2 transmission and reconciling with seroprevalence estimates
Rupam Bhattacharyya, Ritoban Kundu, Ritwik Bhaduri, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 22
Rapid incidence estimation from SARS-CoV-2 genomes reveals decreased case detection in Europe during summer 2020
Maureen Rebecca Smith, Maria Trofimova, Ariane Weber, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 21
Laser induced breakdown spectroscopy for the rapid detection of SARS-CoV-2 immune response in plasma
Kim Berlo, Weiming Xia, Florentine Zwillich, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 14
COVID-19 primary series and booster vaccination and potential for immune imprinting
Hiam Chemaitelly, Houssein H. Ayoub, Patrick Tang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 14
Estimated number of symptomatic Lyme borreliosis cases in Germany in 2021 after adjusting for under-ascertainment
Julia Olsen, Frederick J. Angulo, Andreas Pilz, et al.
Public Health (2023) Vol. 219, pp. 1-9
Open Access | Times Cited: 8
Estimated Number of Symptomatic Lyme Borreliosis Cases in Adults in Finland in 2021 Using Seroprevalence Data to Adjust the Number of Surveillance-Reported Cases: A General Framework for Accounting for Underascertainment by Public Health Surveillance
Julia Olsen, Frederick J. Angulo, Andreas Pilz, et al.
Vector-Borne and Zoonotic Diseases (2023) Vol. 23, Iss. 4, pp. 265-272
Open Access | Times Cited: 8
Narratives and the Policy Process : Applications of the Narrative Policy Framework
Elizabeth A. Shanahan
(2021)
Open Access | Times Cited: 18
SARS-CoV-2 incidence and risk factors in a national, community-based prospective cohort of U.S. adults
Denis Nash, Madhura S. Rane, Mindy Chang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 17
Disparities in SARS-CoV-2 Infection by Race, Ethnicity, Language, and Social Vulnerability: Evidence from a Citywide Seroprevalence Study in Massachusetts, USA
Wilfredo R. Matias, Isabel Fulcher, Sara Sauer, et al.
Journal of Racial and Ethnic Health Disparities (2023) Vol. 11, Iss. 1, pp. 110-120
Open Access | Times Cited: 6
Prospective Clinical Assessments of Hospitalized Patients With Positive SARS-CoV-2 PCR Tests for Necessity of Isolation
Chanu Rhee, Meghan A. Baker, Sanjat Kanjilal, et al.
Open Forum Infectious Diseases (2021) Vol. 8, Iss. 7
Open Access | Times Cited: 14
Seroprevalence and SARS-CoV-2 invasion in general populations: A scoping review over the first year of the pandemic
Clémentine Metzger, Taylor Leroy, Agathe Bochnakian, et al.
PLoS ONE (2023) Vol. 18, Iss. 4, pp. e0269104-e0269104
Open Access | Times Cited: 5
Estimated Incidence of Symptomatic Lyme Borreliosis Cases in Lublin, Poland in 2021
Emily Colby, Julia Olsen, Frederick J. Angulo, et al.
Microorganisms (2023) Vol. 11, Iss. 10, pp. 2481-2481
Open Access | Times Cited: 5
Stochastic social behavior coupled to COVID-19 dynamics leads to waves, plateaus and an endemic state
Alexei V. Tkachenko, Sergei Maslov, Tong Wang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 13
Severe Acute Respiratory Syndrome Coronavirus 2 Incidence and Risk Factors in a National, Community-Based Prospective Cohort of US Adults
Denis Nash, Madhura S. Rane, McKaylee Robertson, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. e375-e384
Open Access | Times Cited: 9

Scroll to top